A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer — Stella
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
(10 sites) United States
The Angeles Clinic and Research Institute, Los Angeles, California Sylvester Comprehensive Cancer Center, Miami, Florida Orlando Health Cancer Institute, Orlando, Florida Moffitt Cancer Center, Tampa, Florida The University of Kansas Cancer Center, Westwood, Kansas University of Louisville, Louisville, Kentucky Memorial Sloan Kettering Cancer Center, New York, New York University of Cincinnati, Cincinnati, Ohio UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania Medical College of Wisconsin, Milwaukee, Wisconsin
Last updated December 2024